Ryerson (RYI)
(Real Time Quote from BATS)
$24.54 USD
+0.22 (0.91%)
Updated May 23, 2024 10:18 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
RYI 24.54 +0.22(0.91%)
Will RYI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RYI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RYI
Ryerson's (RYI) Q4 Earnings Beat, Revenues Miss Estimates
Ryerson Holding (RYI) to Report Q4 Earnings: What's in the Offing?
RYI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ryerson Holding (RYI) Suffers a Larger Drop Than the General Market: Key Insights
Ryerson Holding (RYI) Rises Higher Than Market: Key Facts
Ryerson Holding (RYI) Advances While Market Declines: Some Information for Investors
Other News for RYI
Oppenheimer Keeps Their Buy Rating on Viracta Therapeutics (VIRX)
Wall Street Breakfast: The Week Ahead
July 19th Options Now Available For Ryerson Holding (RYI)
Underpriced Stocks: 3 Hidden Gems Worth Snagging Now
Viracta Therapeutics Welcomes New CFO and Outlines Compensation